127 related articles for article (PubMed ID: 3128509)
1. The molecular heterogeneity of nonspecific cross-reacting antigen synthesized by tumor cells and granulocytes.
Kuroki M; Kuroki M; Moore GE; Ichiki S; Matsuoka Y
Jpn J Cancer Res; 1988 Jan; 79(1):82-90. PubMed ID: 3128509
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
Audette M; Buchegger F; Schreyer M; Mach JP
Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
[TBL] [Abstract][Full Text] [Related]
3. Production kinetics and immunochemical properties of carcinoembryonic antigen and nonspecific cross-reacting antigen synthesized by various human tumor cell lines.
Ichiki S; Kuroki M; Kuroki M; Koga Y; Matsuoka Y
Jpn J Cancer Res; 1986 May; 77(5):462-72. PubMed ID: 2426231
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of nonspecific cross-reacting antigens in human granulocytes.
Kuroki M; Arakawa F; Matsuo Y; Oikawa S; Misumi Y; Nakazato H; Matsuoka Y
J Biol Chem; 1991 Jun; 266(18):11810-7. PubMed ID: 2050678
[TBL] [Abstract][Full Text] [Related]
5. Nonspecific cross-reacting antigen (NCA) expressed by human granulocytes: six species with different peptide sizes and membrane anchoring forms.
Kuroki M; Matsuo Y; Kuroki M; Matsuoka Y
Biochem Biophys Res Commun; 1990 Jan; 166(2):701-8. PubMed ID: 2154215
[TBL] [Abstract][Full Text] [Related]
6. Three different NCA species, CGM6/CD67, NCA-95, and NCA-90, are comprised in the major 90 to 100-kDa band of granulocyte NCA detectable upon SDS-polyacrylamide gel electrophoresis.
Kuroki M; Matsuo Y; Kinugasa T; Matsuoka Y
Biochem Biophys Res Commun; 1992 Jan; 182(2):501-6. PubMed ID: 1370882
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a species of non-specific cross-reacting antigen (NCA) expressed by human monocytic cell lines: structure and expression during cell differentiation.
Kuroki M; Yamanaka T; Matsuo Y; Ohtani T; Matsuo Y; Minowada J; Misumi Y; Oikawa S; Nakazato H; Matsuoka Y
Int J Cancer; 1994 Mar; 56(6):886-91. PubMed ID: 8119777
[TBL] [Abstract][Full Text] [Related]
8. The subunit structure of non-specific cross-reacting antigen (NCA).
Krop-Watorek A; Sedlaczek P; Lisowska E
Mol Immunol; 1983 Jul; 20(7):777-85. PubMed ID: 6412074
[TBL] [Abstract][Full Text] [Related]
9. Coproduction of carcinoembryonic antigen and nonspecific cross-reacting antigen by a continuous cell line from a human pancreatic tumor.
Kuroki M; Ichiki S; Kuroki M; Matsuoka Y
J Natl Cancer Inst; 1982 Aug; 69(2):401-8. PubMed ID: 6810002
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a cDNA clone encoding a new species of the nonspecific cross-reacting antigen (NCA), a member of the CEA gene family.
Arakawa F; Kuroki M; Misumi Y; Oikawa S; Nakazato H; Matsuoka Y
Biochem Biophys Res Commun; 1990 Feb; 166(3):1063-71. PubMed ID: 2306228
[TBL] [Abstract][Full Text] [Related]
11. Two CEA and three NCA species, although distinguishable by monoclonal antibodies, have nearly identical peptide patterns.
Grunert F; AbuHarfeil N; Schwarz K; von Kleist S
Int J Cancer; 1985 Sep; 36(3):357-62. PubMed ID: 3839768
[TBL] [Abstract][Full Text] [Related]
12. Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein.
Ho MK; Kato KP; Durda PJ; Murray JH; Wolfe H; Rabin H; Carney WP
Cancer Res; 1987 Jan; 47(1):241-50. PubMed ID: 3539319
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the cell surface expression of a nonspecific cross-reacting antigen variant during differentiation of HL-60 cells.
Novak-Hofer I; Bläuenstein P; Schubiger PA
Cancer Res; 1990 Dec; 50(23):7437-43. PubMed ID: 2174725
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
[TBL] [Abstract][Full Text] [Related]
16. Expression of complementary DNA and genomic clones for carcinoembryonic antigen and nonspecific cross-reacting antigen in Chinese hamster ovary and mouse fibroblast cells and characterization of the membrane-expressed products.
Hefta LJ; Schrewe H; Thompson JA; Oikawa S; Nakazato H; Shively JE
Cancer Res; 1990 Apr; 50(8):2397-403. PubMed ID: 2317824
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of a 95-kDa protein--carcinoembryonic antigen-related cell adhesion molecule 8--from normal human granulocytes.
Zhao L; Xu S; Peterson C; Kuroki M; Kuroki M; Venge P
J Immunol Methods; 2002 Dec; 270(1):27-35. PubMed ID: 12379336
[TBL] [Abstract][Full Text] [Related]
18. Identification and partial characterization of the unglycosylated peptide of carcinoembryonic antigen synthesized by human tumor cell lines in the presence of tunicamycin.
Kuroki M; Kuroki M; Ichiki S; Matsuoka Y
Mol Immunol; 1984 Aug; 21(8):743-6. PubMed ID: 6205259
[TBL] [Abstract][Full Text] [Related]
19. CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells.
Kuijpers TW; Hoogerwerf M; van der Laan LJ; Nagel G; van der Schoot CE; Grunert F; Roos D
J Cell Biol; 1992 Jul; 118(2):457-66. PubMed ID: 1378450
[TBL] [Abstract][Full Text] [Related]
20. Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.
Noworolska A; Harłozińska A; Richter R; Brodzka W
Br J Cancer; 1985 Mar; 51(3):371-7. PubMed ID: 3882113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
